Category archives: Personalized Medicine
-
- One of the things that surprised me when I first became a patient advocate for Sanguine BioSciences was how “normal” all of my patients were. Many of the diseases we work with on a daily basis have names that sound scary, like Parkinson’s, Alzheimer’s, and Lupus. Most of us picture these people with[...]
-
- Human embryonic stem cells - the earliest cells within a fertilized human blastocyst (a 4-5 days old embryo consisting of just 150-200 cells) - hold great potential for cell replacement therapies, where cells are lost due to disease and/or injury. Why is this the case? Well, embryonic stem cells hav[...]
-
- Besides the need of patient biospecimen for new drug development, those specimens are also necessary for the development of new diagnostics – biomarkers. A biomarker is a biological molecule (DNA, protein, etc.) found in blood or tissues, indicating a certain state of a disease or condition.
For [...]
-
-
Biobanking is one of "10 Ideas Changing the World Right Now"- Time Magazine
Biobanks are key to our future. For this reason, in 2009, Time Magazine listed the biobanking as one of the Top 10 ideas changing the world.
Generally speaking, a biobank is defined as a repository that collects and st[...]
-
- In the past, most doctors used a "one-size-fits-all" approach when treating their patients with a given drug. Starting off with standard doses, they then observed how well (or not) patients responded and then, if necessary, changed the doses or drugs by a "trial and error" process.
Nowadays, doct[...]
